Search results
A total of 47% in the drug condition versus 21% in the placebo condition achieved remission (p=.07). Weight Loss Mean BMI decreased from 41.1 to 40.9 in the drug condition versus an increase from 34.2 to 35.7 in the placebo condition, which indicated a significantly greater advantage for the citalopram group (p<.001).
- Pharmacological treatment of binge eating disorder: update ... - PubMed
The evidence base regarding pharmacotherapy for BED remains...
- Pharmacological management of binge eating disorder: current and ...
Growing evidence suggests that pharmacotherapy may be...
- Table 1, DSM-IV and DSM-5 diagnostic criteria for binge-eating disorder ...
The binge eating is not associated with the regular use of...
- Pharmacological treatment of binge eating disorder: update ... - PubMed
The evidence base regarding pharmacotherapy for BED remains limited, although this year the FDA approved the first medication (i.e., lisdexamfetamine dimesylate; LDX) specifically for moderate-to-severe BED. Data from RCTs suggest certain medications are superior to placebos for reducing binge eatin ….
Growing evidence suggests that pharmacotherapy may be beneficial for some patients with binge eating disorder (BED), an eating disorder characterized by repetitive episodes of uncontrollable consumption of abnormally large amounts of food without inappropriate weight loss behaviors.
The binge eating is not associated with the regular use of inappropriate compensatory behavior (e.g., purging, fasting, excessive exercise) and does not occur exclusively during the course of anorexia nervosa or bulimia nervosa. DSM-IV does not include a BED severity grading scale.
2 mar 2018 · With regard to pharmaceutical treatments, SSRIs and lisdexamfetamine resulted in remission and decreased frequency of binge eating episodes at the end of treatment with low quality evidence. However, the long-term effect of pharmacotherapy is largely unknown.
Growing evidence suggests that pharmacotherapy may be beneficial for some patients with binge eating disorder (BED), an eating disorder characterized by repetitive episodes of uncontrollable consumption of abnormally large amounts of food without inappropriate weight loss behaviors.
Abstract: Growing evidence suggests that pharmacotherapy may be beneficial for some patients with binge eating disorder (BED), an eating disorder characterized by repetitive episodes of uncontrollable consumption of abnormally large amounts of food without inappropriate weight loss behaviors.
